Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome

Anderson R. L., Hiemstra P. S., Ward C., Forrest I. A., Murphy D., Proud D., Lordan J., Corris P. A., Fisher A. J.

Source: Eur Respir J 2008; 32: 670-677
Journal Issue: September

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anderson R. L., Hiemstra P. S., Ward C., Forrest I. A., Murphy D., Proud D., Lordan J., Corris P. A., Fisher A. J.. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 2008; 32: 670-677

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008



Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004

Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 179s
Year: 2004

Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004



Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
Source: Eur Respir J 2008; 31: 1037-1045
Year: 2008



Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011


Post-transplant bronchiolitis obliterans
Source: Eur Respir J 2003 Dec 01;22(6):1007-1018
Year: 2003



The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004

Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Year: 2006


Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet?
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55
Year: 2004

Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004

Post-transplant bronchiolitis obliterans
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158
Year: 2003

Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005



Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004



Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Protein profiling in two different phenotypes of bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011